Open AccessA prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin's lymphoma following treatment with iodine-131-rituximab radio-immunotherapy
Author(s) -
Mark Bishton,
Rodney J. Hicks,
David Westerman,
Miles Prince,
Max Wolf,
John F. Seymour
Publication year - 2008
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.12253
Subject(s) - rituximab , medicine , lymphoma , oncology , hodgkin lymphoma , prospective cohort study , nuclear medicine